# Cronos Group Inc. (CRON)

**Exchange:** NASDAQ  
**Sector:** Healthcare  
**Market cap:** $1.06B  
**Price:** $2.75 (+0.55%)

> Cronos Group Inc. is a global cannabinoid company focused on building iconic brands and advancing research, technology, and product development in medical and adult-use cannabis markets. It operates primarily in Canada, Israel, and international regions including Europe, offering a diverse portfolio of premium cannabis products such as flower, pre-rolls, vapes, gummies, and extracts. Key brands include Spinach® for innovative edibles and vapes like PUFFERZ™, SOURZ®, and seasonal flavors; Lord Jones® for high-potency live resin fusions and indoor-grown flower; and PEACE NATURALS® for medical cannabis distribution. The company leverages cultivation through Cronos GrowCo, emphasizing small-batch production, liquid diamonds infusion, and terpene-rich formulations to meet consumer demand for quality, convenience, and potency. Cronos Group Inc. pursues strategic international partnerships and transactions, such as expanding into Switzerland and the Netherlands' adult-use pilot program, positioning it as a key player in the evolving global cannabis industry. Founded in 2018 and headquartered in Toronto, Canada, it supports borderless product strategies across recreational and medicinal segments.

## Income Statement (Annual, USD)

| Fiscal Year | Revenue | Gross Profit | Operating Income | Net Income | EPS (dil.) |
| --- | --- | --- | --- | --- | --- |
| 2025 | $147M | $63M | -$17M | -$9M | — |
| 2024 | $118M | $25M | -$77M | $41M | — |
| 2023 | $87M | $12M | -$85M | -$74M | — |
| 2022 | $87M | $15M | -$111M | -$169M | — |
| 2021 | $65M | -$18M | -$292M | -$396M | — |
| 2020 | $47M | -$26M | -$219M | -$73M | — |
| 2019 | $24M | -$18M | -$153M | $1.17B | — |
| 2018 | $12M | $6M | -$20M | -$22M | — |
| 2017 | $3M | $2M | -$6M | -$1M | — |

## Balance Sheet (Annual, USD)

| Fiscal Year | Total Assets | Total Liabilities | Equity | Cash | Long-term Debt |
| --- | --- | --- | --- | --- | --- |
| 2025 | $1.20B | $54M | $1.09B | $792M | — |
| 2024 | $1.17B | $55M | $1.06B | $859M | — |
| 2023 | $1.14B | $44M | $1.10B | $669M | — |
| 2022 | $1.21B | $72M | $1.14B | $765M | — |
| 2021 | $1.40B | $63M | $1.34B | $887M | — |
| 2020 | $1.93B | $218M | $1.71B | $1.08B | — |
| 2019 | $2.09B | $341M | $1.75B | $1.20B | — |
| 2018 | $183M | $35M | $148M | $24M | — |

## Cash Flow (Annual, USD)

| Fiscal Year | Operating Cash Flow | CapEx | Free Cash Flow |
| --- | --- | --- | --- |
| 2025 | $26M | $26M | $149,000 |
| 2024 | $19M | $12M | $6M |
| 2023 | -$43M | $3M | -$45M |
| 2022 | -$89M | $3M | -$92M |
| 2021 | -$154M | $11M | -$165M |
| 2020 | -$145M | $31M | -$176M |
| 2019 | -$131M | $39M | -$170M |
| 2018 | -$8M | $88M | -$96M |
| 2017 | -$4M | $33M | -$37M |

Source: [CompaniesByCap](https://companiesbycap.com/company/CRON)